RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hanmi Science Co Stock

Hanmi Science Co Revenue 2024

Hanmi Science Co Revenue

1.25 T KRW

Ticker

008930.KS

ISIN

KR7008930000

In 2024, Hanmi Science Co's sales reached 1.25 T KRW, a 19.3% difference from the 1.05 T KRW sales recorded in the previous year.

The Hanmi Science Co Revenue history

YEARREVENUE (undefined KRW)GROSS MARGIN (%)
20231.2518,88
20221.0515,33
20210.9513,97
20200.8614,08
20190.8213,27
20180.7113,05
20170.6514,05
20160.6712,80
20150.7827,89
20140.5312,85
20130.2225,70
20120.0295,71
20110.0294,77
20100.0191,01
20090.6960,99
20080.6164,35
20070.5367,15
20060.4468,03
20050.465,05
20040.3461,44

Hanmi Science Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Hanmi Science Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Hanmi Science Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Hanmi Science Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Hanmi Science Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Hanmi Science Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Hanmi Science Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Hanmi Science Co’s growth potential.

Hanmi Science Co Revenue, EBIT and net profit per share

DateHanmi Science Co RevenueHanmi Science Co EBITHanmi Science Co Net Income
20231.25 T undefined57.01 B undefined115.12 B undefined
20221.05 T undefined28.11 B undefined69.21 B undefined
2021950.16 B undefined28.75 B undefined42.94 B undefined
2020857.38 B undefined25.15 B undefined22.6 B undefined
2019816.62 B undefined16.15 B undefined30.74 B undefined
2018708 B undefined11 B undefined18.02 B undefined
2017652.32 B undefined13.97 B undefined30.07 B undefined
2016665.29 B undefined15.07 B undefined7.94 B undefined
2015776.63 B undefined147.07 B undefined178.52 B undefined
2014532.89 B undefined9.29 B undefined21.31 B undefined
2013220.4 B undefined6.82 B undefined9.58 B undefined
201220.18 B undefined4.15 B undefined12.48 B undefined
201117.35 B undefined3.07 B undefined-14.69 B undefined
201010.98 B undefined2.73 B undefined6.98 B undefined
2009691.98 B undefined74.94 B undefined50.53 B undefined
2008606.8 B undefined81.69 B undefined71.55 B undefined
2007531.4 B undefined80.81 B undefined53 B undefined
2006444.69 B undefined66.51 B undefined72.41 B undefined
2005396.02 B undefined58.99 B undefined41.85 B undefined
2004344.8 B undefined44.17 B undefined30 B undefined

Hanmi Science Co stock margins

The Hanmi Science Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Hanmi Science Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Hanmi Science Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Hanmi Science Co's sales revenue. A higher gross margin percentage indicates that the Hanmi Science Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Hanmi Science Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Hanmi Science Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Hanmi Science Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Hanmi Science Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Hanmi Science Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Hanmi Science Co Margin History

Hanmi Science Co Gross marginHanmi Science Co Profit marginHanmi Science Co EBIT marginHanmi Science Co Profit margin
202318.88 %4.57 %9.23 %
202215.33 %2.69 %6.62 %
202113.97 %3.03 %4.52 %
202014.08 %2.93 %2.64 %
201913.27 %1.98 %3.76 %
201813.05 %1.55 %2.55 %
201714.05 %2.14 %4.61 %
201612.8 %2.26 %1.19 %
201527.89 %18.94 %22.99 %
201412.85 %1.74 %4 %
201325.7 %3.1 %4.35 %
201295.71 %20.55 %61.84 %
201194.77 %17.72 %-84.69 %
201091.01 %24.87 %63.56 %
200960.99 %10.83 %7.3 %
200864.35 %13.46 %11.79 %
200767.15 %15.21 %9.97 %
200668.03 %14.96 %16.28 %
200565.05 %14.9 %10.57 %
200461.44 %12.81 %8.7 %

Hanmi Science Co Aktienanalyse

What does Hanmi Science Co do?

Hanmi Science Co Ltd is a South Korean company specializing in the manufacturing of pharmaceutical products, biologics, and medical devices. The company was founded in 1973 as a chemical company and obtained the license for drug manufacturing in 1990, expanding its product range to include pharmaceuticals. Today, the company's business model includes three main areas: research and development, manufacturing and sales of drugs, and sales of medical devices. Hanmi aims to develop and produce innovative and high-quality products to improve people's health worldwide. In the field of research and development, Hanmi Science is a leading company. It specializes in the research and development of novel drugs and biologics. The company has an impressive track record in the development and marketing of innovative drugs for the treatment of diabetes, cancer, and rare diseases. This includes a range of biosimilars produced using biotechnological methods that are more affordable compared to original medical substances. Hanmi also has a state-of-the-art production infrastructure that meets the highest quality standards and ensures reliable supply. In the field of drug manufacturing, the company produces generics and biosimilars that are sold in more than 50 countries worldwide. Hanmi also specializes in the production of chemotherapeutics and parenteral drugs that have proven efficacy and safety. The medical device sales division focuses on marketing high-quality medical devices, including diagnostic and monitoring devices used in the medical field. Hanmi also distributes a range of medical consumables, including transfusion sets, syringes, infusion sets, and catheters. Hanmi Science Co Ltd offers a wide range of products that can be categorized into various categories. Among the pharmaceutical products are antidiabetic drugs, anticancer agents, antidepressants, antibiotics, antiviral medications, and products for the treatment of rare diseases. The portfolio also includes biosimilars of botulinum toxin, insulin, and humiderm among the biologics. Overall, Hanmi Science Co Ltd holds a strong position in the South Korean market and has also established a good reputation internationally. With its focus on research and development and the production of high-quality drugs and medical devices, the company has a promising future. Hanmi Science Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Hanmi Science Co's Sales Figures

The sales figures of Hanmi Science Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Hanmi Science Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Hanmi Science Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Hanmi Science Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Hanmi Science Co stock

How much revenue did Hanmi Science Co generate this year?

Hanmi Science Co has achieved a revenue of 1.25 T KRW this year.

How much was the turnover of the company Hanmi Science Co compared to the previous year?

The revenue of Hanmi Science Co has increased by 19.3% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Hanmi Science Co?

The revenue of Hanmi Science Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Hanmi Science Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Hanmi Science Co so important for investors?

The revenue of Hanmi Science Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Hanmi Science Co pay?

Over the past 12 months, Hanmi Science Co paid a dividend of 200 KRW . This corresponds to a dividend yield of about 0.54 %. For the coming 12 months, Hanmi Science Co is expected to pay a dividend of 200 KRW.

What is the dividend yield of Hanmi Science Co?

The current dividend yield of Hanmi Science Co is 0.54 %.

When does Hanmi Science Co pay dividends?

Hanmi Science Co pays a quarterly dividend. This is distributed in the months of January, January, January, July.

How secure is the dividend of Hanmi Science Co?

Hanmi Science Co paid dividends every year for the past 7 years.

What is the dividend of Hanmi Science Co?

For the upcoming 12 months, dividends amounting to 200 KRW are expected. This corresponds to a dividend yield of 0.54 %.

In which sector is Hanmi Science Co located?

Hanmi Science Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hanmi Science Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hanmi Science Co from 8/14/2024 amounting to 100 KRW, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Hanmi Science Co pay the last dividend?

The last dividend was paid out on 8/14/2024.

What was the dividend of Hanmi Science Co in the year 2023?

In the year 2023, Hanmi Science Co distributed 196.078 KRW as dividends.

In which currency does Hanmi Science Co pay out the dividend?

The dividends of Hanmi Science Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hanmi Science Co

Our stock analysis for Hanmi Science Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hanmi Science Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.